HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruijun Cai Selected Research

Ruijun Cai Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 04/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2014
1Eye Diseases (Eye Disease)
01/2023
1Adenocarcinoma of Lung
01/2022
1Carcinoma (Carcinomatosis)
01/2022
1Malnutrition (Nutritional Deficiencies)
02/2020
1Neoplasm Metastasis (Metastasis)
10/2019
1Lung Neoplasms (Lung Cancer)
10/2019
1Esophageal Neoplasms (Esophageal Cancer)
05/2018
1Esophageal Squamous Cell Carcinoma
01/2017
1Diarrhea
04/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2013
1Atrioventricular Block
01/2013
1Hypoxia (Hypoxemia)
09/2012
1Hypertrophy
09/2012
1Ventricular Fibrillation
04/2012
1Hemorrhage
04/2012

Drug/Important Bio-Agent (IBA)

2Long Noncoding RNAIBA
01/2022 - 10/2019
2Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2012
1PolymersIBA
01/2023
1osimertinibIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1AntigensIBA
01/2022
1AutoantibodiesIBA
01/2022
1Complementary DNA (cDNA)IBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1CrizotinibIBA
01/2019
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2017
1PlatinumIBA
04/2014
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2014
1Docetaxel (Taxotere)FDA Link
04/2014
1MicroRNAs (MicroRNA)IBA
01/2013
1CalcineurinIBA
09/2012
1Messenger RNA (mRNA)IBA
09/2012

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2022 - 04/2014
2Length of Stay
02/2020 - 04/2012
1Neoadjuvant Therapy
01/2022
1Esophagectomy
05/2018
1VDA-P protocol
04/2014
1Operative Surgical Procedures
04/2012
1Thoracotomy
04/2012